News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
553,461 Results
Type
Article (12309)
Company Profile (189)
Press Release (540870)
Multimedia
Podcasts (9)
Webinars (9)
Section
Business (185377)
Career Advice (507)
Deals (28138)
Drug Delivery (27)
Drug Development (60943)
Employer Resources (31)
FDA (10879)
Job Trends (9934)
News (266676)
Policy (20296)
Tag
2027 BioCapital Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (4)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (789)
Accelerated approval (29)
ADA (28)
Adcomms (2)
Allergies (123)
Alliances (38612)
ALS (155)
Alzheimer's disease (1166)
Antibody-drug conjugate (ADC) (357)
Approvals (11553)
Artificial intelligence (450)
ASCO (211)
Autoimmune disease (274)
Automation (40)
Bankruptcy (269)
Best Places to Work (7917)
BIO (60)
Biologics (2)
BIOSECURE Act (14)
Biosimilars (140)
BioSpace Insights (28)
Biotechnology (134)
Bladder cancer (162)
Brain cancer (42)
Breast cancer (632)
Cancer (4549)
Cardiovascular disease (254)
Career advice (438)
Career pathing (7)
CAR-T (253)
CDC (3)
Celiac Disease (1)
Cell therapy (676)
Cervical cancer (43)
Clinical research (55286)
Collaboration (1661)
Commercialization (4)
Compensation (1510)
Complete response letters (37)
COVID-19 (1062)
CRISPR (80)
C-suite (1028)
Cystic fibrosis (114)
Data (6937)
Denatured (4)
Depression (116)
Dermatology (71)
Diabetes (437)
Diagnostics (4800)
Digital health (42)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (249)
Drug pricing (27)
Drug shortages (4)
Duchenne muscular dystrophy (207)
Earnings (77926)
Editorial (9)
Employer branding (2)
Employer resources (32)
Events (99488)
Executive appointments (906)
FDA (13999)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (19)
Frontotemporal dementia (31)
Funding (1274)
Gene editing (157)
Generative AI (33)
Gene therapy (455)
GLP-1 (441)
Government (1286)
Grass and pollen (2)
Guidances (306)
Healthcare (10558)
Hematology (117)
HIV (61)
Huntington's disease (31)
IgA nephropathy (84)
Immunology and inflammation (121)
Immuno-oncology (73)
Indications (182)
Infectious disease (1289)
Inflammatory bowel disease (156)
Inflation Reduction Act (6)
Influenza (107)
Intellectual property (293)
Interviews (58)
IPO (13497)
IRA (6)
Job creations (2408)
Job search strategy (408)
JPM (5)
Kidney cancer (17)
Labor market (18)
Layoffs (98)
Leadership (4)
Legal (5555)
Licensing (10)
Liver cancer (59)
Longevity (27)
Lung cancer (592)
Lymphoma (351)
Machine learning (39)
Management (7)
Manufacturing (740)
Marketing (9)
MASH (136)
Medical device (9438)
Medtech (9590)
Mergers & acquisitions (15797)
Metabolic disorders (932)
mRNA (89)
Multiple sclerosis (142)
NASH (5)
Neurodegenerative disease (290)
Neuropsychiatric disorders (49)
Neuroscience (2274)
Neurotech (1)
NextGen: Class of 2026 (3708)
Non-profit (1166)
Now hiring (6)
Obesity (335)
Opinion (62)
Ovarian cancer (187)
Pain (203)
Pancreatic cancer (267)
Parkinson's disease (286)
Partnered (16)
Patents (552)
Patient recruitment (650)
Peanut (40)
People (47550)
Pharmaceutical (34)
Pharmacy benefit managers (9)
Phase 1 (18064)
Phase 2 (24864)
Phase 3 (16568)
Pipeline (8628)
Policy (61)
Postmarket research (1713)
Preclinical (7691)
Press Release (66)
Prostate cancer (225)
Psychedelics (10)
Radiopharmaceuticals (222)
Rare diseases (714)
Real estate (3956)
Recruiting (15)
Regulatory (17187)
Reports (30)
Research institute (866)
Resumes & cover letters (69)
Rett syndrome (45)
RNA editing (10)
RSV (52)
Schizophrenia (127)
Series A (231)
Series B (171)
Service/supplier (5)
Sickle cell disease (86)
Special edition (3)
Spinal muscular atrophy (110)
Sponsored (12)
Startups (2533)
State (1)
Stomach cancer (5)
Supply chain (67)
Tariffs (10)
The Weekly (5)
Vaccines (414)
Venture capital (36)
Weight loss (133)
Women's health (90)
Worklife (2)
Date
Today (62)
Last 7 days (266)
Last 30 days (1843)
Last 365 days (22680)
2026 (14733)
2025 (22838)
2024 (26633)
2023 (30468)
2022 (39395)
2021 (42472)
2020 (38253)
2019 (27545)
2018 (20805)
2017 (22611)
2016 (21507)
2015 (27884)
2014 (24261)
2013 (20716)
2012 (22763)
2011 (23178)
2010 (22593)
Location
Africa (368)
Alabama (80)
Alaska (3)
Arizona (316)
Arkansas (13)
Asia (24946)
Australia (4442)
California (12997)
Canada (3458)
China (880)
Colorado (516)
Connecticut (468)
Delaware (256)
Europe (46971)
Florida (1923)
Georgia (413)
Hawaii (4)
Idaho (51)
Illinois (826)
India (85)
Indiana (508)
Iowa (22)
Japan (462)
Kansas (112)
Kentucky (35)
Louisiana (29)
Maine (28)
Maryland (1346)
Massachusetts (9045)
Michigan (318)
Minnesota (621)
Mississippi (5)
Missouri (87)
Montana (32)
Nebraska (11)
Nevada (136)
New Hampshire (67)
New Jersey (2950)
New Mexico (24)
New York (3106)
North Carolina (1442)
North Dakota (8)
Northern California (6619)
Ohio (305)
Oklahoma (16)
Oregon (21)
Pennsylvania (2492)
Puerto Rico (23)
Rhode Island (34)
South America (565)
South Carolina (78)
South Dakota (1)
Southern California (5290)
Tennessee (130)
Texas (2065)
United States (43236)
Utah (390)
Vermont (1)
Virginia (178)
Washington D.C. (44)
Washington State (1044)
West Virginia (2)
Wisconsin (101)
Wyoming (3)
553,461 Results for "ixcells biotechnologies usa inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
iXCells Biotechnologies Selected to Perform the First Pilot in Patient-Led ALS Precision Medicine Effort
August 26, 2025
·
5 min read
Biotech Beach
iXCells Biotechnologies Announces Grand Opening and 2024 Rare Disease Month Workshop
iXCells Biotechnologies USA, Inc. announced the grand opening celebration of its new San Diego headquarters and Rare Disease Month Workshop.
February 1, 2024
·
3 min read
Press Releases
iXCells Biotechnologies Launches iPSCore™ Platform for Generating Highly Characterized iPSC-derived Human Cell Models
June 12, 2025
·
4 min read
Business
iXCells Biotechnologies Strengthens Leadership Team; Welcomes New CEO
iXCells Biotechnologies USA, Inc., a cell technology company specializing in providing cell-based products and drug discovery service solutions to the global academic, biotech, pharmaceutical, and rare disease communities, announced the appointment of Helge Bastian, PhD, as the company’s new Chief Executive Officer.
January 18, 2024
·
4 min read
Biotech Beach
iXCells Biotechnologies Expands Operations; New Website Goes Live
iXCells Biotechnologies USA, Inc., a cell technology company specializing in providing cell-based products and drug discovery solutions to the global academic, biotech and pharmaceutical communities, announced completing key growth initiatives.
September 6, 2023
·
2 min read
Press Releases
AIVITA Biomedical Nominated for 2026 Prix Galien USA Award
August 14, 2026
·
4 min read
Press Releases
Takara Bio USA, Inc. Announces the Retirement of Carol Lou, Appoints Andrew Farmer as President and CEO
July 9, 2026
·
4 min read
Press Releases
MediBeacon Transdermal GFR System Nominated for 2026 Prix Galien USA Best Medical Technology
August 18, 2026
·
3 min read
Press Releases
Takara Bio USA, Inc. to Showcase Instrument-Free Approach to Spatial Biology at Human Cell Atlas 2026 Meeting
June 16, 2026
·
4 min read
Press Releases
Alembic Therapeutics, LLC Announces Acquisition of NUVESSA® (metronidazole vaginal gel 1.3%) from Exeltis USA, Inc.
June 9, 2026
·
1 min read
1 of 55,347
Next
